Medications for Intraductal Noninfiltrating Carcinoma

5 results

  • tamoxifen citrate

    (Tamoxifen Citrate)
    Dr. Reddy's Laboratories Inc.
    Tamoxifen citrate tablets are indicated for the treatment of metastatic breast cancer, node-positive and node-negative adjuvant breast cancer, ductal carcinoma in situ (DCIS), and to reduce breast cancer incidence in high-risk women. It is particularly effective for estrogen receptor-positive tumors and requires individual risk assessment for therapy.

  • tamoxifen citrate

    (Tamoxifen Citrate)
    Proficient Rx LP
    Tamoxifen citrate tablets are indicated for treating metastatic breast cancer, as adjuvant therapy post-surgery in node-positive and node-negative cases, for reducing invasive breast cancer risk in women with ductal carcinoma in situ, and for decreasing breast cancer incidence in high-risk women.

  • tamoxifen citrate

    (Tamoxifen Citrate)
    Aurobindo Pharma Limited
    Tamoxifen citrate tablets are indicated for treating metastatic breast cancer in both women and men, serving as an adjuvant therapy post-mastectomy, and for reducing invasive breast cancer risk in women with DCIS. Additionally, it is prescribed to high-risk women to lower breast cancer incidence based on specific risk criteria.

  • tamoxifen citrate

    (Tamoxifen Citrate)
    NuCare Pharmaceuticals,Inc.
    Tamoxifen citrate is indicated for treating metastatic breast cancer, adjuvant therapy after surgery, and ductal carcinoma in situ (DCIS). It also reduces breast cancer incidence in high-risk women. Efficacy is greater in estrogen receptor-positive tumors, and individual risk assessments are crucial when considering therapy.

  • tamoxifen citrate

    (Tamoxifen Citrate)
    Bryant Ranch Prepack
    Tamoxifen citrate tablets are indicated for treating metastatic and node-positive breast cancer in men and women, reducing contralateral breast cancer risk, and adjunctive therapy post-surgery. They also reduce invasive breast cancer risk in women with ductal carcinoma in situ and are indicated for preventing breast cancer in high-risk women.